🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study in healthy male subjects to investigate whether administration of A...
Status
Completed
Location
Cepha s.r.o.
Start Date
2017-10-30
Trial ID
NCT03339752
Treatments Being Tested
So far, ACT-541468 has been studied mainly in Caucasian subjects. The prese...
Status
Completed
Location
Centre for Human Drug Research
Start Date
2017-03-15
Trial ID
NCT03101189
Treatments Being Tested
The main objectives of this first-into-man study were to investigate the sa...
Status
Completed
Location
Investigator Site
Start Date
2015-02-01
Trial ID
NCT02919319
This study evaluates the dose response of ACT-541468 on the change of wake ...
Status
Completed
Location
Investigator Site
Start Date
2016-11-28
Trial ID
NCT02841709
Treatments Being Tested
The main purpose of this study is to assess efficacy and safety of ACT-5414...
Status
Completed
Location
Pinnacle Research Group, LLC
Start Date
2018-06-04
Trial ID
NCT03545191
Treatments Being Tested
The purpose of this study is to evaluate the tolerability, safety, pharmaco...
Status
Completed
Location
Investigator Site
Start Date
2015-10-01
Trial ID
NCT02571855
Treatments Being Tested
The main objectives of this phase 1 trial are to evaluate the effect of foo...
Status
Completed
Location
Investigator Site
Start Date
2017-01-01
Trial ID
NCT03017495
Treatments Being Tested
Study of the way the body takes up, distributes, and gets rid of ACT-541468...
Status
Completed
Location
APEX GmbH
Start Date
2019-09-24
Trial ID
NCT04024332
Treatments Being Tested
This study evaluates the dose response of ACT-541468 on the change of WASO ...
Status
Completed
Location
Investigator Site
Start Date
2016-10-04
Trial ID
NCT02839200
Treatments Being Tested
Study to assess the long term safety and tolerability of daridorexant in ad...
Status
Completed
Location
Pulmonary Associates of the Southeast/WCR
Start Date
2018-10-09
Trial ID
NCT03679884
Treatments Being Tested